No results for ‘’
Zim Laboratories Ltd
₹100.05
(0.94%)
Mon, 25 May 2026, 08:11 pm
Health Technology
Pharmaceuticals: Generic
24.5KZim Laboratories Share Price Live Chart
1 Day
(0.94%)
No Result Found
Summary
Market Cap
535.70
Net Profit
12.17
P/B
1.56
Sector P/E
34.11
P/E
32.08
EV/EBITDA
10.22
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.05
RONW (Industry)
13.18
ROE
4.96
ROCE
8.16
Debt/Equity
0.47
EPS (TTM)
1.09
Dividend Yield
0
Book Value
55.31
Interest Cover
2.58
Analysis
all
- Dividends paid are well covered by earnings (4.1x coverage).
- ZIM Laboratories is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- ZIM Laboratories is profitable, therefore cash runway is not a concern.
- ZIM Laboratories is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (28.4%, greater than 20% of total debt).
- ZIM Laboratories has only been paying a dividend for 2 years, and since then there has been no growth.
- Whilst dividend payments have been stable, ZIM Laboratories has been paying a dividend for less than 10 years.
- ZIM Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- ZIM Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Interest payments on debt are not well covered by earnings (EBIT is 0.6x annual interest expense, ideally 3x coverage).
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 30.34 | 33.26 | 33.26 | 33.26 | 33.26 |
| FII | 0 | 0.02 | 0 | 0.03 | 0.01 |
| DII | 0.07 | 0.20 | 0.24 | 0.24 | 0.24 |
| Public | 69.58 | 66.52 | 66.51 | 66.46 | 66.49 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 136.89 | 108.30 | 98.12 | 79.71 | 69.53 | 51.12 | 22.53 |
| Fibonacci | 108.30 | 97.38 | 90.63 | 79.71 | 68.79 | 62.04 | 51.12 |
| Camarilla | 95.80 | 93.18 | 90.56 | 79.71 | 85.32 | 82.70 | 80.08 |
Pivots Level: Classic
R3
+57.18
136.89
R2
+28.59
108.30
R1
+18.41
98.12
S1
-10.18
69.53
S2
-28.59
51.12
S3
-57.18
22.53
Moving Average
Period
Value
10-EMA
99.35
20-EMA
95.80
30-EMA
91.95
50-EMA
86.44
100-EMA
80.84
200-EMA
80.70
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 19 May 2026 | board-meetings | Accounts | |
| 11 Feb 2026 | board-meetings | Quarterly Results, Half Yearly Results | |
| 21 Jan 2026 | egm | ||
| 03 Jun 2025 | agm | ||
| 06 Jun 2024 | agm | ||
| 20 May 2024 | agm | Annual General Meeting | 21 Jun 2024 |
| 15 Jun 2023 | agm | ||
| 03 Jun 2023 | agm | Annual General Meeting | 04 Jul 2023 |
| 12 Dec 2022 | bonus | 2:1 Bonus Issue of Equity Shares | 22 Dec 2022 |
| 22 Nov 2022 | bonus | Bonus issue 2:1 | 22 Dec 2022 |
Peer Comparison
Zim Laboratories Ltd
Torrent Pharmaceuticals Ltd
Dr Reddys Laboratories Ltd
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Divis Laboratories Ltd
Zim Laboratories Ltd About
Zim Laboratories is engaged in the manufacturing of formulation drugs and pre formulation ingredients in India and marketing and selling these within and outside India.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1984
Headquarters
CEO
Anwar S Daud
Employees
Contact
Website
http://www.zimlab.in
cs@zimlab.in
Phone
91-712-2588070
Location
Sadoday Gyan (Gr Floor), Opp NADT Nelson Square, Nagpur, Maharashtra, 440013
Zim Laboratories Ltd Company History
| Year | History |
|---|---|
| 1992 |
|
| 1993 |
|
| 2018 |
|
| 2022 |
|
| 2023 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ELIMATH ADVISORS PRIVATE LIMITED | bulk | Buy | 3840000 | 73.47 | 11 Nov 2025 |
| ELIZABETH MATHEW | bulk | Sell | 3840000 | 73.45 | 11 Nov 2025 |
| AJIT RAMKARAN SARDA | bulk | Sell | 142892 | 82.02 | 29 Oct 2025 |
| AJIT RAMKARAN SARDA | bulk | Buy | 265483 | 81.58 | 29 Oct 2025 |
| ELIMATH ADVISORS PRIVATE LIMITED | bulk | Buy | 1497124 | 68.79 | 24 Oct 2025 |
| MATHEW CYRIAC | bulk | Sell | 1569000 | 68.84 | 24 Oct 2025 |
| MATHEW CYRIAC | bulk | Buy | 1794000 | 115.31 | 17 Jul 2025 |
| ELIZABETH MATHEW | bulk | Sell | 1794000 | 115.31 | 17 Jul 2025 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Buy | 41859 | 99.73 | 20 Mar 2025 |
| YUGA STOCKS AND COMMODITIES PRIVATE LIMITED | bulk | Sell | 477321 | 93.51 | 20 Mar 2025 |